Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$0.6 - $1.53 $450 - $1,147
750 New
750 $0
Q3 2022

Oct 26, 2022

SELL
$1.9 - $8.63 $475 - $2,157
-250 Reduced 25.0%
750 $2,000
Q2 2022

Jul 22, 2022

BUY
$2.13 - $9.01 $532 - $2,252
250 Added 33.33%
1,000 $2,000
Q4 2020

Feb 23, 2021

BUY
$39.09 - $57.4 $29,317 - $43,050
750 New
750 $31,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Orion Capital Management LLC Portfolio

Follow Orion Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Capital Management LLC with notifications on news.